In the context of cancer, functional redundancy can significantly influence the effectiveness of therapeutic interventions. Cancer cells often exploit redundant pathways to survive and proliferate, even when one pathway is inhibited. This redundancy can lead to resistance against targeted therapies, making it challenging to achieve long-term remission.
